Oppenheimer Adjusts Cigna's Price Target to $300 From $285, Maintains Outperform Rating
© MT Newswires 2022
All news about CIGNA CORPORATION |
|
06:48a | JPMorgan Raises Cigna to Overweight From Neutral, Price Target to $304 From $248 | MT |
05/11 | TRANSCRIPT : Cigna Corporation Presents at Bank of America 2022 Healthcare Conference, May.. | CI |
05/10 | Raymond James Adjusts Cigna's Price Target to $300 From $275, Keeps Strong Buy Rating | MT |
05/09 | Goldman Sachs Raises Cigna's Price Target to $273 From $239, Maintains Neutral Rating | MT |
05/09 | Truist Securities Adjusts Cigna's Price Target to $310 from $290, Keeps Buy Rating | MT |
05/09 | UBS Adjusts Cigna Price Target to $310 From $300, Maintains Buy Rating | MT |
05/09 | WALL STREET STOCK EXCHANGE : We've had better days | |
05/09 | Oppenheimer Adjusts Cigna's Price Target to $310 From $300, Maintains Outperform Rating | MT |
05/09 | ANALYST RECOMMENDATIONS : Lowe's, Match Group, Shopify, Simmons, Williams-Sonoma... | |
05/09 | RBC Boosts Price Target on Cigna to $272 From $235, Maintains Sector Perform Rating | MT |
|
|
Analyst Recommendations on CIGNA CORPORATION |
|
|
| |
|
Sales 2022 |
179 B
-
-
|
Net income 2022 |
5 236 M
-
-
|
Net Debt 2022 |
25 696 M
-
-
|
P/E ratio 2022 |
15,4x |
Yield 2022 |
1,65% |
|
Capitalization |
82 234 M
82 234 M
-
|
EV / Sales 2022 |
0,60x |
EV / Sales 2023 |
0,57x |
Nbr of Employees |
72 963 |
Free-Float |
79,5% |
|
|
Duration :
Period :
|
 |
|
Technical analysis trends CIGNA CORPORATION
| Short Term | Mid-Term | Long Term | Trends | Neutral | Bullish | Bullish |
Income Statement Evolution
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
23 |
Last Close Price |
259,19 $ |
Average target price |
281,96 $ |
Spread / Average Target |
8,78% |
|